Navigation Links
NORTHWEST BIO Will Present at the Second Annual "Cancer Immunotherapy: A Long Awaited Reality Conference" at the New York Academy of Medicine, October 6, 2011
Date:10/4/2011

tage clinical trials," Ms. Powers continued.  "In the trials so far, patients who received the DCVax® dendritic cell treatments lived for years longer than patients receiving standard of care (not just weeks or months longer), and without toxicity.  Building upon the original discovery of dendritic cells by Dr. Steinman, we are working to make dendritic cell treatments widely available for patients, and believe that such treatments have the potential to become a new standard of care for most cancers."

The Company's broad platform technology for dendritic cell-based vaccines is currently being tested in an ongoing 240-patient Phase II clinical trial for newly diagnosed Glioblastoma multiforme ("GBM") -- the most aggressive and lethal form of brain cancer.  The Company also previously received clearance from the FDA for a 612-patient Phase III trial in prostate cancer, and clearance from the FDA for Phase I trials in multiple other cancers.  The Company has also conducted a Phase I/II trial with DCVax® for recurrent metastatic ovarian cancer.

Dr. Maida joined the Company in June, 2011, as Chief Operating Officer ("COO"), bringing more than 20 years' experience in building oncology companies, with expertise in the business, financial, clinical and regulatory aspects of oncology products, as well as the underlying science.  Over these two decades, Dr. Maida has held positions as Chairman, CEO, COO, CSO, CFO and VP Business Development, and has raised nearly $200 million in financings for oncology companies.  Among these experiences, he served as CEO of CancerVax, an early leader in cancer vaccines.  In that role, he raised the company's first $30 million of funding, and was responsible for conducting multi-hundred patient, multi-center clinical trials with the company's cancer vaccines.  Prior to joining NORTHWEST BIO, Dr. Maida was serving as Global Head of Oncology for a leading contract research organiz
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in the US and Europe
2. Cord Blood America Enters Agreement With Regence, Serving BlueCross and BlueShield Programs in the Northwest U.S. and Mountain Regions
3. Dendreon CEO Dr. Mitchell Gold Named Ernst & Young Entrepreneur Of The Year® 2011 Pacific Northwest Award Winner
4. Northwest Biotherapeutics Announces Change and Expansion of Management Team
5. Northwest Biotherapeutics Announces Series of Financing Arrangements
6. Northwest Biotherapeutics to Present at American Society of Cell and Gene Therapy
7. Northwest Biotherapeutics and the Fraunhofer Institute for Cell Therapy and Immunology are Partnering for Clinical Trials and Compassionate Use Cases in Europe
8. Northwest Biotherapeutics Addresses Recent Market Activity
9. Cell Therapeutics, Inc. (CTI) to Present at Life Science Innovation Northwest
10. Registration Open for WBBAs Life Science Innovation Northwest 2011 Event Webcast
11. BioSpace Highlights the Northwests Growing Life Science Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... High performance computing (HPC) will be ... climate and Earth system model to address the ... Eight national laboratories, including Lawrence Livermore , ... Atmospheric Research, four academic institutions and one private-sector ... laboratories include Argonne, Brookhaven, Lawrence Berkeley, Los Alamos, ...
(Date:8/20/2014)... JOSE, Calif. , Aug. 20, 2014 /PRNewswire-iReach/ ... highlights the transformative collaboration between the school,s bioengineering ... As part of the Intel® Software Academic Program, ... computer sciences and the human body.  ... The study exhibits the work of Dr. ...
(Date:8/19/2014)... 19, 2014 Shimadzu Scientific Instruments ... Prominence-i and Nexera-i, adding to the company’s extensive ... functionality, an intuitive operating environment, and full automation, ... efficient workflow for conventional to ultra-high-speed analysis. ... and intelligent design so users can begin building ...
(Date:8/19/2014)... Robin Williams’ passing is a sad reminder ... individual. Symptoms range from slowness of voluntary movements ... severe depression. Parkinson’s disease progressively gets worse over ... neurons of the brain. As these patients struggle ... progressively gets worse, they look for options. ...
Breaking Biology Technology:New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 3Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research 2Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 2Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 3As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 2As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 3
... LAIYANG, China, Nov. 3 /Xinhua-PRNewswire-FirstCall/ -- Genesis,Pharmaceuticals ... or,the "Company"), a U.S. pharmaceutical company with ... China, today announced the launch of its ... ., The website features an ...
... Nov. 3 Altogen Biosystems (http://www.altogen.com ),announced ... laboratories and research facilities for animal testing. Transfection ... introduce DNA and RNA molecules,into cells and tissues. ... barriers and deliver a gene or a small ...
... NLTX ), announced today that Peter Strumph, Chief ... -- Rodman & Renshaw 10th Annual Healthcare Conference ... Monday, November 10, 2008 at The Palace Hotel in,New ... Healthcare Conference at 9:00 a.m.,ET on Wednesday, November 19, ...
Cached Biology Technology:Genesis Pharmaceuticals Launches New Corporate Website 2Altogen Biosystems Launches New Nanoparticle-based In Vivo Transfection Reagent 2Nile Therapeutics to Present at Two Upcoming Investor Conferences 2
(Date:8/20/2014)... causes a burning spiciness that is irresistible to some, ... effect are using their findings to develop a new ... be caused by inflammation or other problems. They reported ... in clinical trials, in ACS, Journal of Medicinal ... decades ago, scientists had pegged a compound called capsaicin ...
(Date:8/20/2014)... about 4,000 members, it triggers an important first stage ... type of comb used for rearing male reproductive, called ... Neurobiology and Behaviour at Cornell University, led by Michael ... colonies. The results are published in Springer,s journal ... Reproduction isn,t always a honeybee colony,s top priority. ...
(Date:8/19/2014)... must be made to decrease China,s increasing caesarean section ... in BJOG: An International Journal of Obstetrics and ... highest caesarean delivery rates in the world. Of 16 ... caesarean. Although the exact rate is not known, the ... reports total caesarean rates ranging from 36% to 58%. ...
Breaking Biology News(10 mins):Worker bees 'know' when to invest in their reproductive future 2Is China's 50 percent cesarean section delivery rate too high? 2Is China's 50 percent cesarean section delivery rate too high? 3
... Residents along the Gulf Coast are bracing for Hurricane Ike ... through Cuba and Haiti. ESA,s Envisat satellite is tracking the ... coast by 13 September. Knowing the strength and path ... (EO) satellites are key means of providing synoptic data on ...
... Leonid Yaroslavsky from Tel Aviv University, the saying may be ... humans may have an ability to "see" colors and shapes ... a chapter of a new book, Advances in Information ... form of optical imaging technology that beats the limitations of ...
... to increase usability and adoption of SMS and mobile ... Social ... Systems,Corporation, a leading developer of innovative voice-powered mobile,applications, unveiled today ... highly accurate voice dictation system. Using the company,s proprietary,Client Server ...
Cached Biology News:Hurricane Ike tracked by ESA's Envisat 2Seeing through the skin 2Promptu Unveils High Accuracy Voice-to-Text Dictation for Mobile Phones at CTIA 2
MHC. Sections include: the isolation and functional properties of antigen-presenting cells analysis of MHC class II endocytosis and peptide turnover analysis of signalling via MHC class II molecu...
... The 1-D PAGE Cleavable ... for Targeted Protein ID ... PolyAcrylamide Gel Electrophoresis (PAGE), ... and cleavable-linker technology to ...
Supplemental reagent for annexin V assay....
Antibody Purification Specificity: Antibody Purification ...
Biology Products: